Ratio Therapeutics Raises $50M in Series B Financing
FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!
Source: finsmes.com
📰 Jack Hoppin News
Jack Hoppin News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Jack Hoppin. Real-time updates on events, politics, business and more.
Ratio Therapeutics unveils new research and development facility
Boston-based radiopharmaceutical company Ratio Therapeutics has opened a new 19,000 square foot headquarters and R&D facility.
Source: biopharma-reporter.com
EMIT IMAGING Announces Appointment of Dr. Matthew Silva as Chief Executive Officer
BALTIMORE — EMIT IMAGING, Inc. (“EMIT” or the “Company”) is pleased to announce the appointment of Dr. Matthew Silva as the company’s new Chief Executive…
Source: financialpost.com
Ratio Therapeutics Announces Licensing Agreement for Investigational PET Imaging Agent with Merck
Collaboration to develop a Granzyme B-targeted agent for PET imaging applications in inflammation and cancer indications
Source: itnonline.com
Ratio Therapeutics Appoints Dr. Noel Monks as Head of Biology
/PRNewswire/ -- Ratio Therapeutics Inc. (Ratio), a pharmaceutical company specializing in the development of targeted radiotherapeutics for the treatment of...
United States John Babich Erica Fiorini Jack Hoppin Astrazeneca Medimmune University Of Newcastle Upon Tyne
Source: prnewswire.com
Ratio Therapeutics Announces $20M Series A Financing to Advance Targeted Radiotherapies for Cancer Treatment
/PRNewswire/ -- Ratio Therapeutics Inc., a pharmaceutical company specializing in the development of targeted radiotherapeutics for the treatment of cancer,...
Source: prnewswire.com
Ratio Therapeutics Raises $20M in Series A Financing
FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!
Source: finsmes.com
Ratio Therapeutics Appoints Reed Malleck as Chief Financial Officer
/PRNewswire/ -- Ratio Therapeutics Inc. (Ratio), a pharmaceutical company that employs a suite of innovative technologies to develop best-in-class targeted...
Source: prnewswire.com
Ratio Therapeutics Appoints Jacob Hesterman, Ph.D., as Chief Data Officer
/PRNewswire/ -- Ratio Therapeutics Inc., a pharmaceutical company that employs a suite of innovative technologies to develop best-in-class targeted...
Source: prnewswire.com
Ratio Therapeutics Launches to Discover and Drive Early Clinical Development of Best-in-Class Targeted Radiopharmaceuticals for Treatment of Cancers
/PRNewswire/ -- Ratio Therapeutics Inc. today announced its launch with a mission to develop best-in-class targeted radiopharmaceuticals for the treatment of...
Source: prnewswire.com